Cargando…
Targeted Therapy in Follicular Lymphoma: Towards a Chemotherapy-Free Approach
SIMPLE SUMMARY: Follicular lymphoma (FL)—a common, indolent, and usually non-curable B-cell non-Hodgkin lymphoma—is frequently treated with cytotoxic chemotherapy with anti-CD20 therapy. The downsides of this approach include cumulative toxicities that limit the total duration of treatment and may b...
Autores principales: | Chen, Chung-Jiah J., Choi, Michael Y., Heyman, Benjamin M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526830/ https://www.ncbi.nlm.nih.gov/pubmed/37760453 http://dx.doi.org/10.3390/cancers15184483 |
Ejemplares similares
-
Chemotherapy-Free Management of Follicular and Marginal Zone Lymphoma
por: Ollila, Thomas A, et al.
Publicado: (2021) -
Targeted Treatment of Follicular Lymphoma
por: Nath, Karthik, et al.
Publicado: (2021) -
New targets for the treatment of follicular lymphoma
por: Tageja, Nishant, et al.
Publicado: (2009) -
T follicular helper cells: a potential therapeutic target in follicular lymphoma
por: Ochando, Jordi, et al.
Publicado: (2017) -
Targeted Therapy for Relapsed/Refractory Follicular Lymphoma: Focus on Clinical Utility of Tazemetostat
por: Raychaudhuri, Ruben, et al.
Publicado: (2022)